View Financial HealthSunjin Beauty ScienceLtd 배당 및 자사주 매입배당 기준 점검 1/6Sunjin Beauty ScienceLtd 은(는) 현재 수익률이 2.67% 인 배당금 지급 회사입니다.핵심 정보2.7%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률2.7%배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 8.9% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).분석 기사 • Nov 10Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has Affirmed Its Dividend Of ₩60.00Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) has announced that it will pay a dividend of ₩60.00 per share on the...Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 42% over the next year, which should provide support to the dividend and adequate earnings cover.공시 • Nov 07Sunjin Beauty Science Co.Ltd announces Annual dividend, payable on April 28, 2026Sunjin Beauty Science Co.Ltd announced Annual dividend of KRW 60.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 30 April 2025. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 1.2% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩8,200, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 7.7% over the past three years.분석 기사 • May 25We Believe That Sunjin Beauty ScienceLtd's (KOSDAQ:086710) Weak Earnings Are A Good Indicator Of Underlying ProfitabilityThe recent earnings release from Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) was disappointing to investors. We...Valuation Update With 7 Day Price Move • May 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩8,690, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 10% over the past three years.New Risk • Apr 20New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩123.7b market cap, or US$83.9m).New Risk • Mar 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩116.3b market cap, or US$77.0m).Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,300, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past three years.공시 • Feb 24Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South KoreaUpcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 8.9% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).분석 기사 • Nov 21Sunjin Beauty ScienceLtd (KOSDAQ:086710) Strong Profits May Be Masking Some Underlying IssuesSunjin Beauty Science Co.Ltd's ( KOSDAQ:086710 ) stock didn't jump after it announced some healthy earnings. Our...Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩101 (vs ₩92.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩101. Revenue: ₩18.9b (up 3.4% from 3Q 2024). Net income: ₩808.3m (down 27% from 3Q 2024). Profit margin: 4.3% (down from 6.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in South Korea.Buy Or Sell Opportunity • Nov 14Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₩9,350. The fair value is estimated to be ₩11,755, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 20% in a year. Earnings are forecast to grow by 49% in the next year.분석 기사 • Nov 10Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has Affirmed Its Dividend Of ₩60.00Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) has announced that it will pay a dividend of ₩60.00 per share on the...Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 42% over the next year, which should provide support to the dividend and adequate earnings cover.공시 • Nov 07Sunjin Beauty Science Co.Ltd announces Annual dividend, payable on April 28, 2026Sunjin Beauty Science Co.Ltd announced Annual dividend of KRW 60.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.New Risk • Aug 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩134.2b (US$95.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Market cap is less than US$100m (₩134.2b market cap, or US$95.7m).분석 기사 • May 22Sunjin Beauty ScienceLtd's (KOSDAQ:086710) Solid Profits Have Weak FundamentalsLast week's profit announcement from Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) was underwhelming for investors...New Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).분석 기사 • May 19These 4 Measures Indicate That Sunjin Beauty ScienceLtd (KOSDAQ:086710) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • May 03We Like These Underlying Return On Capital Trends At Sunjin Beauty ScienceLtd (KOSDAQ:086710)There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩15,190, the stock trades at a trailing P/E ratio of 20x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 85% over the past three years.New Risk • Apr 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).분석 기사 • Apr 17Earnings Tell The Story For Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) As Its Stock Soars 34%Despite an already strong run, Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have been powering on, with a gain...Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩13,350, the stock trades at a trailing P/E ratio of 17.6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 53% over the past three years.분석 기사 • Apr 09At ₩10,670, Is Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Worth Looking At Closely?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it saw a double-digit share price...New Risk • Mar 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₩138.4b market cap, or US$94.4m).분석 기사 • Feb 21Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Popularity With Investors Is ClearWith a price-to-earnings (or "P/E") ratio of 17.4x Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) may be sending...공시 • Feb 21Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 30 April 2025. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).분석 기사 • Dec 16Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩9,740, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩92.00 (vs ₩13.00 in 3Q 2023)Third quarter 2024 results: EPS: ₩92.00 (up from ₩13.00 in 3Q 2023). Revenue: ₩18.2b (up 19% from 3Q 2023). Net income: ₩1.10b (up ₩943.2m from 3Q 2023). Profit margin: 6.1% (up from 1.1% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩9,230, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years.분석 기사 • Nov 04Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₩10,750, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past three years.분석 기사 • Aug 04Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) 30% Cheaper Price Remains In Tune With EarningsThe Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) share price has softened a substantial 30% over the previous 30...Buy Or Sell Opportunity • Aug 02Now 22% undervaluedOver the last 90 days, the stock has risen 38% to ₩12,220. The fair value is estimated to be ₩15,613, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.분석 기사 • Jul 27Is Sunjin Beauty ScienceLtd (KOSDAQ:086710) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...분석 기사 • Jul 04What Does Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Share Price Indicate?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it received a lot of attention from...Valuation Update With 7 Day Price Move • Jul 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,470, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 73% over the past three years.Buy Or Sell Opportunity • Jul 01Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 122% to ₩17,860. The fair value is estimated to be ₩14,271, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.분석 기사 • Jun 19After Leaping 94% Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Shares Are Not Flying Under The RadarSunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have continued their recent momentum with a 94% gain in the last...Buy Or Sell Opportunity • Jun 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 174% to ₩21,250. The fair value is estimated to be ₩17,414, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩22,200, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 132% over the past three years.Buy Or Sell Opportunity • Jun 14Now 27% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to ₩22,200. The fair value is estimated to be ₩17,446, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.분석 기사 • Jun 06Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...New Risk • May 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Profit margins are more than 30% lower than last year (8.4% net profit margin).Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩15,500, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩271 (vs ₩225 in 1Q 2023)First quarter 2024 results: EPS: ₩271 (up from ₩225 in 1Q 2023). Revenue: ₩20.8b (up 2.0% from 1Q 2023). Net income: ₩3.25b (up 20% from 1Q 2023). Profit margin: 16% (up from 13% in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩10,460, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 11% over the past three years.분석 기사 • Apr 23Does Sunjin Beauty ScienceLtd (KOSDAQ:086710) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 1.2% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).New Risk • Nov 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 31% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₩91.6b market cap, or US$70.6m).Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩7,960, the stock trades at a trailing P/E ratio of 4.6x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past year.Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩10,560, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past year.Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₩8,520, the stock trades at a trailing P/E ratio of 5.2x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 17% over the past year.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩6,950, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past year.Upcoming Dividend • Dec 21Upcoming dividend of ₩10.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 26 April 2023. Payout ratio is a comfortable 6.6% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (2.4%).Valuation Update With 7 Day Price Move • Dec 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,250, the stock trades at a trailing P/E ratio of 47.2x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past year.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩6,410, the stock trades at a trailing P/E ratio of 43x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 13% over the past year.Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,210, the stock trades at a trailing P/E ratio of 34.9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 41% over the past year.Valuation Update With 7 Day Price Move • Jun 22Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,530, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past year.Buying Opportunity • May 10Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.8%. The fair value is estimated to be ₩9,160, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.0% over the last year. Earnings per share has declined by 64%.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩21,400, the stock trades at a trailing P/E ratio of 50.5x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 5.6% over the past year.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩14,850, the stock trades at a trailing P/E ratio of 35x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 44% over the past year.Buying Opportunity • Jan 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be ₩17,656, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last year. Earnings per share has declined by 32% over the last year.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 배당금 지급이 안정적인 반면, A086710 은(는) 배당금을 지급한 지 10년도 채 되지 않았습니다.배당금 증가: A086710 의 배당금 지급이 증가했지만 회사는 5 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장Sunjin Beauty ScienceLtd 배당 수익률 vs 시장A086710의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (A086710)2.7%시장 하위 25% (KR)1.2%시장 상위 25% (KR)4.3%업계 평균 (Chemicals)1.5%분석가 예측 (A086710) (최대 3년)2.7%주목할만한 배당금: A086710 의 배당금( 2.67% )은 KR 시장에서 배당금 지급자의 하위 25%( 1.23% )보다 높습니다.고배당: A086710 의 배당금( 2.67% )은 KR 시장에서 배당금 지급자의 상위 25%( 4.27% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 A086710 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: A086710 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YKR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/02 03:39종가2026/07/02 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sunjin Beauty Science Co.Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 8.9% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
분석 기사 • Nov 10Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has Affirmed Its Dividend Of ₩60.00Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) has announced that it will pay a dividend of ₩60.00 per share on the...
Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 42% over the next year, which should provide support to the dividend and adequate earnings cover.
공시 • Nov 07Sunjin Beauty Science Co.Ltd announces Annual dividend, payable on April 28, 2026Sunjin Beauty Science Co.Ltd announced Annual dividend of KRW 60.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 30 April 2025. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 1.2% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩8,200, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 7.7% over the past three years.
분석 기사 • May 25We Believe That Sunjin Beauty ScienceLtd's (KOSDAQ:086710) Weak Earnings Are A Good Indicator Of Underlying ProfitabilityThe recent earnings release from Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) was disappointing to investors. We...
Valuation Update With 7 Day Price Move • May 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩8,690, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 10% over the past three years.
New Risk • Apr 20New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩123.7b market cap, or US$83.9m).
New Risk • Mar 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩116.3b market cap, or US$77.0m).
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,300, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past three years.
공시 • Feb 24Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South Korea
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 8.9% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
분석 기사 • Nov 21Sunjin Beauty ScienceLtd (KOSDAQ:086710) Strong Profits May Be Masking Some Underlying IssuesSunjin Beauty Science Co.Ltd's ( KOSDAQ:086710 ) stock didn't jump after it announced some healthy earnings. Our...
Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩101 (vs ₩92.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩101. Revenue: ₩18.9b (up 3.4% from 3Q 2024). Net income: ₩808.3m (down 27% from 3Q 2024). Profit margin: 4.3% (down from 6.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in South Korea.
Buy Or Sell Opportunity • Nov 14Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₩9,350. The fair value is estimated to be ₩11,755, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 20% in a year. Earnings are forecast to grow by 49% in the next year.
분석 기사 • Nov 10Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has Affirmed Its Dividend Of ₩60.00Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) has announced that it will pay a dividend of ₩60.00 per share on the...
Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 42% over the next year, which should provide support to the dividend and adequate earnings cover.
공시 • Nov 07Sunjin Beauty Science Co.Ltd announces Annual dividend, payable on April 28, 2026Sunjin Beauty Science Co.Ltd announced Annual dividend of KRW 60.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
New Risk • Aug 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩134.2b (US$95.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Market cap is less than US$100m (₩134.2b market cap, or US$95.7m).
분석 기사 • May 22Sunjin Beauty ScienceLtd's (KOSDAQ:086710) Solid Profits Have Weak FundamentalsLast week's profit announcement from Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) was underwhelming for investors...
New Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).
분석 기사 • May 19These 4 Measures Indicate That Sunjin Beauty ScienceLtd (KOSDAQ:086710) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • May 03We Like These Underlying Return On Capital Trends At Sunjin Beauty ScienceLtd (KOSDAQ:086710)There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩15,190, the stock trades at a trailing P/E ratio of 20x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 85% over the past three years.
New Risk • Apr 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
분석 기사 • Apr 17Earnings Tell The Story For Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) As Its Stock Soars 34%Despite an already strong run, Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have been powering on, with a gain...
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩13,350, the stock trades at a trailing P/E ratio of 17.6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 53% over the past three years.
분석 기사 • Apr 09At ₩10,670, Is Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Worth Looking At Closely?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it saw a double-digit share price...
New Risk • Mar 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₩138.4b market cap, or US$94.4m).
분석 기사 • Feb 21Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Popularity With Investors Is ClearWith a price-to-earnings (or "P/E") ratio of 17.4x Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) may be sending...
공시 • Feb 21Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 30 April 2025. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
분석 기사 • Dec 16Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩9,740, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.
Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩92.00 (vs ₩13.00 in 3Q 2023)Third quarter 2024 results: EPS: ₩92.00 (up from ₩13.00 in 3Q 2023). Revenue: ₩18.2b (up 19% from 3Q 2023). Net income: ₩1.10b (up ₩943.2m from 3Q 2023). Profit margin: 6.1% (up from 1.1% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩9,230, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years.
분석 기사 • Nov 04Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₩10,750, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past three years.
분석 기사 • Aug 04Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) 30% Cheaper Price Remains In Tune With EarningsThe Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) share price has softened a substantial 30% over the previous 30...
Buy Or Sell Opportunity • Aug 02Now 22% undervaluedOver the last 90 days, the stock has risen 38% to ₩12,220. The fair value is estimated to be ₩15,613, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.
분석 기사 • Jul 27Is Sunjin Beauty ScienceLtd (KOSDAQ:086710) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
분석 기사 • Jul 04What Does Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Share Price Indicate?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it received a lot of attention from...
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,470, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 73% over the past three years.
Buy Or Sell Opportunity • Jul 01Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 122% to ₩17,860. The fair value is estimated to be ₩14,271, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.
분석 기사 • Jun 19After Leaping 94% Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Shares Are Not Flying Under The RadarSunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have continued their recent momentum with a 94% gain in the last...
Buy Or Sell Opportunity • Jun 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 174% to ₩21,250. The fair value is estimated to be ₩17,414, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩22,200, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 132% over the past three years.
Buy Or Sell Opportunity • Jun 14Now 27% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to ₩22,200. The fair value is estimated to be ₩17,446, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.
분석 기사 • Jun 06Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
New Risk • May 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Profit margins are more than 30% lower than last year (8.4% net profit margin).
Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩15,500, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩271 (vs ₩225 in 1Q 2023)First quarter 2024 results: EPS: ₩271 (up from ₩225 in 1Q 2023). Revenue: ₩20.8b (up 2.0% from 1Q 2023). Net income: ₩3.25b (up 20% from 1Q 2023). Profit margin: 16% (up from 13% in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩10,460, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 11% over the past three years.
분석 기사 • Apr 23Does Sunjin Beauty ScienceLtd (KOSDAQ:086710) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 1.2% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
New Risk • Nov 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 31% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₩91.6b market cap, or US$70.6m).
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩7,960, the stock trades at a trailing P/E ratio of 4.6x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past year.
Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩10,560, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past year.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₩8,520, the stock trades at a trailing P/E ratio of 5.2x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 17% over the past year.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩6,950, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past year.
Upcoming Dividend • Dec 21Upcoming dividend of ₩10.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 26 April 2023. Payout ratio is a comfortable 6.6% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (2.4%).
Valuation Update With 7 Day Price Move • Dec 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,250, the stock trades at a trailing P/E ratio of 47.2x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past year.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩6,410, the stock trades at a trailing P/E ratio of 43x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 13% over the past year.
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,210, the stock trades at a trailing P/E ratio of 34.9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 41% over the past year.
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,530, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past year.
Buying Opportunity • May 10Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.8%. The fair value is estimated to be ₩9,160, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.0% over the last year. Earnings per share has declined by 64%.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩21,400, the stock trades at a trailing P/E ratio of 50.5x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 5.6% over the past year.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩14,850, the stock trades at a trailing P/E ratio of 35x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 44% over the past year.
Buying Opportunity • Jan 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be ₩17,656, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last year. Earnings per share has declined by 32% over the last year.